background
emag
tm
biomerieux
new
nucleic
acid
extract
platform
base
magnet
silica
technolog
like
predecessor
nuclisen
easymag
biomerieux
use
reagent
dispos
emag
tm
add
autom
allow
simultan
extract
sampl
directli
primari
tube
distribut
nucleic
acid
extract
pcr
strip
tube
end
extract
process
object
compar
perform
emag
tm
easymag
variou
clinic
specimen
studi
design
respiratori
n
whole
blood
n
plasma
n
urin
n
specimen
extract
parallel
platform
qualit
respiratori
viru
cell
control
cmv
ebv
bkv
detect
quantit
respiratori
viru
cell
control
cycl
thresold
cmv
ebv
bkv
viral
load
result
compar
result
detect
qualit
target
show
good
agreement
rang
whole
blood
respiratori
specimen
correl
quantit
result
good
r
rang
quantit
result
show
averag
overal
differ
log
copiesml
emag
tm
easymag
two
platform
show
compar
perform
type
clinic
specimen
test
higher
autom
throughput
easymag
emag
tm
platform
like
advantag
laboratori
perform
larg
number
molecular
analys
molecular
analys
essenti
part
virolog
diagnosi
high
sensit
short
turnaround
time
abil
simultan
detect
quantifi
multipl
rna
dna
virus
small
clinic
sampl
made
gold
standard
diagnos
monitor
viral
infect
nevertheless
perform
also
depend
partli
amount
qualiti
extract
nucleic
acid
na
poor
extract
incomplet
remov
inhibitori
molecul
significantli
undermin
reliabl
molecular
diagnosi
initi
done
centrifug
chemic
separ
extract
mainli
base
na
adsorpt
silica
presenc
chaotrop
salt
sodium
iodid
guanidin
thiocyan
guanidin
hydrochlorid
follow
elut
lowsalt
buffer
water
silicabas
technolog
notabl
improv
boom
colleagu
allow
na
isol
procedur
autom
ensur
better
standard
reproduc
releas
nuclisen
easymag
biomerieux
belong
second
gener
autom
extract
platform
base
silica
extract
technolog
replac
firstgener
nuclisen
minimag
nuclisen
easymag
limit
manual
extract
step
particularli
wash
could
simultan
extract
clinic
specimen
one
hour
perform
clinic
whole
blood
sputum
serum
throat
swab
specimen
qualiti
control
molecular
diagnost
consid
similar
better
manual
autom
na
extract
platform
howev
extract
procedur
fulli
autom
sampl
load
homogen
lyse
sampl
silica
recoveri
elut
na
end
process
requir
human
intervent
third
gener
nuclisen
minimag
easymag
famili
avail
last
quarter
design
fill
gap
base
extract
technolog
use
reagent
dispos
nuclisen
easymag
emag
tm
offer
signific
gain
term
autom
allow
simultan
extract
sampl
directli
primari
tube
distribut
na
extract
pcr
strip
tube
first
necessari
show
gain
practic
undermin
viral
na
extract
perform
comparison
nuclisen
easymag
focu
studi
compar
evalu
new
emag
tm
exist
nuclisen
easymag
extract
devic
clinic
respiratori
whole
blood
plasma
urin
sampl
qualit
quantit
viral
pcr
analys
evalu
carri
juli
clinic
virolog
laboratori
poitier
univers
hospit
franc
two
hundr
ninetynin
residu
discard
clinic
sampl
submit
virolog
mycobacteriolog
depart
virolog
diagnosi
januari
june
retrospect
select
evalu
consist
respiratori
sampl
n
whole
blood
n
edta
plasma
n
urin
n
specimen
describ
next
paragraph
sampl
prospect
test
posit
least
one
viru
time
diagnosi
part
standardofcar
order
clinician
store
c
minim
volum
l
allow
simultan
extract
ident
volum
l
nuclisen
easymag
emag
tm
instrument
prior
realtim
pcr
rtpcr
nucleic
acid
extract
given
sampl
two
platform
amplifi
run
thermocycl
use
throughout
studi
sampl
test
initi
diagnos
viru
test
respiratori
sampl
also
includ
cell
control
detect
local
irb
state
ethic
approv
necessari
research
french
law
respiratori
sampl
select
studi
nasal
aspir
n
tracheal
aspir
n
nasal
swab
n
nasopharyng
swab
n
nasal
wash
n
bronchoalveolar
lavag
fluid
n
store
viral
transport
medium
routin
cmv
ebv
mix
viral
infect
cmvebv
mean
viral
load
one
standard
deviat
sd
cmv
ebv
sampl
respect
copiesml
copiesml
copiesml
also
select
plasma
urin
sampl
posit
bk
viru
bkv
use
easymag
extract
bkv
elit
mgb
kit
analysi
elitech
group
mean
viral
load
respect
copiesml
copiesml
four
hundr
microlit
clinic
sampl
split
two
l
aliquot
extract
parallel
nuclisen
easymag
emag
tm
instrument
biomerieux
accord
manufactur
instruct
two
extract
platform
use
reagent
dispos
respiratori
specimen
distribut
nuclisen
lysi
buffer
tube
contain
ml
lysi
buffer
submit
offboard
lysi
min
room
temperatur
proceed
extract
step
wherea
whole
blood
plasma
urin
sampl
lyse
onboard
ml
lysi
buffer
nuclisen
lysi
buffer
tube
contain
respiratori
sampl
cryogen
vial
cryovial
simport
directli
posit
emag
tm
platform
extract
specif
b
extract
protocol
use
instrument
l
magnet
silica
whole
blood
l
respiratori
urin
plasma
specimen
nucleic
acid
recov
l
elut
buffer
ten
microlit
intern
control
ad
whole
blood
plasma
urin
sampl
prior
extract
extract
run
contain
one
neg
control
nucleic
acid
extract
respiratori
sampl
amplifi
respiratori
multi
well
system
rgene
kit
argen
biomerieux
accord
manufactur
recommend
cmv
ebv
bkv
viral
load
whole
blood
plasma
urin
quantifi
cmv
rgene
biomerieux
respect
realtim
pcr
rtpcr
reaction
perform
abi
fast
devic
appli
biosystem
tabl
show
qualit
result
number
pathogen
detect
obtain
extract
two
platform
kind
specimen
viral
load
mean
one
sd
obtain
viru
extract
whole
blood
plasma
urin
two
system
indic
extract
effici
compar
use
deme
regress
analysi
ct
valu
qualit
analys
respiratori
sampl
includ
respiratori
virus
cell
control
detect
viral
load
valu
quantit
analys
whole
blood
plasma
urin
sampl
blandaltman
plot
use
depict
differ
posit
qualit
ct
quantit
viral
load
result
obtain
emag
tm
easymag
point
repres
observ
differ
result
obtain
two
extract
method
mean
quantit
analys
horizont
line
correspond
log
log
ad
landmark
tabl
graph
gener
sa
softwar
sa
institut
inc
cari
nc
usa
tabl
eight
sampl
posit
initi
diagnosi
retrospect
found
neg
follow
emag
tm
easymag
extract
extract
sampl
volum
l
studi
instead
l
prospect
test
receipt
respiratori
specimen
virolog
diagnosi
like
explain
discrep
howev
nucleic
acid
degrad
specimen
storag
rule
either
discrep
result
two
extract
platform
wellbalanc
emag
tm
n
easymag
n
correspond
respiratori
virus
cell
control
detect
follow
emag
tm
extract
respiratori
virus
detect
easymag
extract
signific
associ
found
discrep
natur
viral
nucleic
acid
rna
dna
specif
viru
speci
singl
multipl
viral
infect
type
respiratori
sampl
shown
ct
valu
discord
respiratori
sampl
exceed
mean
one
case
ct
easymag
extract
detect
emag
tm
extract
ct
valu
obtain
emag
tm
easymag
correl
well
r
respiratori
viru
detect
cell
control
fig
mean
differ
individu
respiratori
viru
detect
emag
tm
easymag
fig
right
side
rang
influenza
b
viru
ct
bocaviru
ct
cell
control
fig
cmv
ebv
target
analyz
sampl
extract
one
specimen
invalid
system
error
emag
tm
platform
qualit
quantit
data
analysi
thu
focus
realtim
quantit
pcr
result
overal
agreement
tabl
ten
discrep
result
observ
wellbalanc
system
sampl
cmv
ebv
posit
emag
tm
extract
detect
easymag
system
vice
versa
ct
valu
exceed
two
sampl
detect
easymag
despit
ct
valu
emag
tm
intern
control
detect
expect
ct
valu
sampl
easymag
extract
mean
cmv
ebv
viral
load
whole
blood
respect
copiesml
easymag
copiesml
emag
tm
overal
correl
coeffici
cmv
ebv
viral
load
respect
valu
differ
mean
viral
load
obtain
emag
tm
versu
easymag
log
copiesml
cmv
ebv
respect
fortyseven
fiftytwo
differ
result
two
extract
method
mean
log
copiesml
fig
total
qualit
quantit
realtim
pcr
result
avail
bkv
plasma
urin
sampl
overal
agreement
invalid
sampl
tabl
three
discrep
result
obtain
plasma
sampl
favor
emag
tm
ct
valu
alway
exceed
viral
load
sampl
posit
extract
method
compar
mean
viral
load
plasma
copiesml
easymag
copiesml
emag
tm
mean
viral
load
urin
copiesml
respect
overal
correl
coeffici
easymag
emag
tm
bkv
viral
load
respect
coeffici
plasma
urin
differ
mean
viral
load
log
copiesml
plasma
urin
respect
averag
overal
differ
log
copiesml
result
includ
analysi
favor
emag
tm
three
differ
result
two
extract
method
mean
exceed
log
copiesml
concern
plasma
sampl
fig
report
first
evalu
emag
tm
latest
autom
nucleic
acid
extract
platform
biomerieux
perform
compar
use
variou
clinic
specimen
predecessor
easymag
thoroughli
evalu
studi
includ
three
hundr
clinic
sampl
consist
mainli
respiratori
specimen
also
whole
blood
plasma
urin
result
assess
qualit
target
consist
respiratori
virus
singleviru
mix
viral
sampl
plu
cell
control
detect
well
quantit
target
repres
cmv
ebv
bkv
viral
load
found
good
agreement
qualit
result
rang
whole
blood
respiratori
sampl
fourteen
falseneg
result
assess
follow
emag
tm
extract
respiratori
sampl
whole
blood
specimen
cmv
ebv
howev
base
equal
number
falseneg
two
platform
well
ct
valu
discrep
result
time
higher
cycl
like
differ
extract
effici
easymag
emag
tm
discrep
result
reflect
targetload
sampl
around
limit
detect
lead
stochast
chanc
detect
regard
clinic
relev
miss
posit
sampl
involv
respiratori
virus
influenza
thu
would
led
delay
lack
treatment
neuraminidas
inhibitor
herpesvirus
viral
load
low
ct
valu
ct
would
like
effect
therapeut
manag
close
monitor
patient
quantit
term
good
correl
viral
load
also
found
r
rang
averag
overal
differ
emag
tm
easymag
less
log
copiesml
result
allow
us
conclud
hand
two
platform
compar
perform
whether
respiratori
whole
blood
plasma
urin
specimen
find
larg
expect
emag
tm
easymag
share
silica
extract
technolog
compar
analysi
necessari
new
emag
tm
extract
platform
significantli
autom
predecessor
interestingli
mean
cmv
ebv
viral
load
measur
whole
blood
favor
emag
tm
log
copiesml
suggest
effici
dna
extract
whole
blood
emag
tm
easymag
inde
comparison
specimen
whole
blood
sampl
extract
report
requir
larger
volum
silica
lysi
buffer
easymag
platform
find
must
howev
confirm
studi
use
larger
number
whole
blood
sampl
new
emag
tm
platform
use
reagent
dispos
protocol
specif
b
studi
easymag
far
practic
emag
tm
manag
na
extract
directli
primari
sampl
tube
ml
therebi
avoid
need
manual
distribut
sampl
vessel
timeconsum
sourc
error
take
account
dead
volum
l
depend
size
shape
input
tube
may
issu
preciou
clinic
sampl
cerebrospin
fluid
aqueou
humor
note
manual
sampl
load
still
possibl
even
tandem
autom
load
run
emag
tm
also
automat
distribut
intern
control
necessari
check
extract
process
absenc
amplif
inhibitor
sampl
silica
limit
handson
time
higher
degre
autom
sampl
reagent
distribut
would
suppos
lower
level
interrun
variat
howev
evalu
present
work
sinc
cell
control
allow
analysi
data
final
na
eluat
transfer
possibl
output
tube
consist
individu
pcr
tube
strip
ml
new
platform
thu
like
significantli
reduc
sampl
process
time
pcr
analysi
improv
standard
traceabl
sampl
extract
limit
risk
error
automat
distribut
clinic
sampl
reagent
howev
noteworthi
extract
one
whole
blood
sampl
invalid
emag
tm
platform
studi
precipit
form
silica
ad
lysi
buffer
contain
specimen
prevent
sampl
handl
instrument
lead
system
error
easymag
platform
manual
homogen
step
allow
us
resuspend
precipit
therebi
enabl
sampl
extract
similar
issu
might
aris
automat
collect
primari
tube
contain
nonhomogen
clinic
sampl
viscou
respiratori
secret
blood
sampl
contain
clot
might
advis
systemat
transfer
certain
sampl
bone
marrow
distal
respiratori
specimen
secondari
tube
order
ensur
fluiditi
posit
emag
tm
instrument
extract
throughput
doubl
emag
tm
compar
easymag
emag
tm
platform
consist
two
independ
section
harbor
reaction
total
simultan
extract
make
emag
tm
advantag
laboratori
analyz
larg
number
sampl
day
extract
take
h
emag
tm
compar
one
hour
easymag
emag
tm
fulli
autom
work
time
spent
task
conclus
emag
tm
show
compar
perform
predecessor
easymag
respiratori
whole
blood
plasma
urin
sampl
evalu
includ
sampl
type
biopsi
amniot
fluid
necessari
complet
autom
higher
throughput
make
emag
tm
platform
particularli
suitabl
laboratori
perform
larg
number
molecular
analys
next
step
interfac
new
extract
platform
pcr
micropl
dispens
nuclisen
easymag
emag
tm
consum
rgene
kit
necessari
evalu
provid
biomerieux
franc
howev
data
obtain
emag
tm
evalu
independ
analyz
virolog
mycobacteriolog
depart
poitier
univers
hospit
possess
entir
final
data
bank
biomerieux
role
studi
design
data
collect
interpret
decis
submit
work
public
